HAWRYLUK P. KENT (President & CEO) purchased 4.5% of their position (20K shares) of MBX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $272.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/21/2025ACC: 0001193125-25-245411
DirectorOfficer· President & CEO
Since Feb 2026
+20K
Net shares
Net buyer
$272.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+20K
Price / share
$13.64
Trade value
$272.79K
% of position
4.5%
10/20/2025
448.28K→468.28K
Total
Net shares
+20K
Net value
$272.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/20/2025 | P · Purchase | +20K | $13.64 | $272.79K | 4.5% | 448.28K | 468.28K |
| Total | +20K | $272.79K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned481.40K
Total
481.40K direct481.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 481.40K | Direct |
| Total | 481.40K | 481.40K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported